< Return to PAMED Public Health

Increased Risk of Withdrawal Symptoms Associated with 7-hydroxymitragynine (7-OH) and Tianeptine After Federal Scheduling

Last Updated

Aug 19, 2026, 15:42 PM

The Drug Enforcement Agency (DEA) has issued two notices of intent to schedule three 7-hydroxymitragynine-related substances and tianeptine. Both 7-hydroxymitragynine (7-OH) and tianeptine products are available through online and retail markets including gas stations, smoke/vape shops, and convenience stores.  Read More.

Load more comments
Login to be able to comment